At 27x price to sales ratio ($53.51 share price), probably the most overvalued stock on the ASX. Even with upgraded forecasts, forward guidance, the institutions are not recommending to buy above $46. Consensus is $39.2 as you can see below. This will be back into the $40's in no time. Will wait to buy back then. $54 is stupid
- Forums
- ASX - By Stock
- WTC
- WiseTech valuation on company provided guidance
WiseTech valuation on company provided guidance, page-63
Featured News
Add WTC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$134.10 |
Change
3.370(2.58%) |
Mkt cap ! $44.18B |
Open | High | Low | Value | Volume |
$131.67 | $134.44 | $130.37 | $22.66M | 171.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 126 | $134.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$134.12 | 54 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 176 | 134.060 |
4 | 73 | 134.050 |
4 | 53 | 134.040 |
8 | 159 | 134.030 |
5 | 78 | 134.020 |
Price($) | Vol. | No. |
---|---|---|
134.190 | 179 | 5 |
134.200 | 817 | 4 |
134.210 | 69 | 2 |
134.220 | 25 | 1 |
134.230 | 69 | 2 |
Last trade - 12.56pm 15/11/2024 (20 minute delay) ? |
Featured News
WTC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online